CD16-CD56bright NK Cells: A Protective NK Cell Subset for Progression and Prognosis in Amyotrophic Lateral Sclerosis
aging and disease · 2024
DOI: 10.14336/ad.2024.1597 ↗Kurz gefasst
Fachartikel in der Zeitschrift aging and disease, 2024. Verfasst von Zhenxiang Gong und 4 weiteren Autor:innen. Beteiligte Einrichtung: department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Killer Cells, Natural, CD56 Antigen, Receptors, IgG. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.
- Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan 430000, China.
- department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.
- department of Neurology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Zitieren
APA
Gong, Z., Ba, L., Li, Z., Hou, H., & Zhang, M. (2024). CD16-CD56bright NK Cells: A Protective NK Cell Subset for Progression and Prognosis in Amyotrophic Lateral Sclerosis. aging and disease. https://doi.org/10.14336/ad.2024.1597
Vancouver
Gong Z, Ba L, Li Z, Hou H, Zhang M. CD16-CD56bright NK Cells: A Protective NK Cell Subset for Progression and Prognosis in Amyotrophic Lateral Sclerosis. aging and disease. 2024. doi:10.14336/ad.2024.1597
BibTeX
@article{Gong2024,
author = {Gong, Zhenxiang and Ba, Li and Li, Zehui and Hou, Hongyan and Zhang, Min},
title = {CD16-CD56bright NK Cells: A Protective NK Cell Subset for Progression and Prognosis in Amyotrophic Lateral Sclerosis},
journal = {aging and disease},
year = {2024},
doi = {10.14336/ad.2024.1597}
}
EUVIMED